EZ-SEQ
DEAD

Serial Number

85547144

Owner

Macrogen Corp

Attorney

Sang Jun Han

First Use Date

Aug 24, 2011

Filing Date

Feb 20, 2012

Add to watchlist:

No watchlists yet
View on USPTO

EZ-SEQ Trademark

Serial Number: 85547144

EZ-SEQ is a trademark filed by Macrogen Corp on February 20, 2012. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Macrogen Corp (10 trademarks)

9700 Great Seneca Highway
Rockville, VA 20850

Entity Type: 03

Trademark Details

Filing Date

February 20, 2012

Registration Date

Not Registered

First Use Anywhere

August 24, 2011

First Use in Commerce

August 24, 2011

Published for Opposition

February 26, 2013

Goods & Services

(Based on Intent to Use) Computer software for scientific analysis of genetic sequences; Diagnostic apparatus for the detection of pathogens for laboratory or research use; DNA chips; Electric heat sequencers; Laboratory devices for detecting genetic sequences; Scientific apparatus and instruments for measuring relative DNA/RNA and protein and parts and fittings therefor; Scientific apparatus, namely, spectrophotometer for measuring relative DNA/RNA and protein; Testing sample collection equipment, namely, wipes and swabs for use in clinical and industrial diagnostic testing

(Based on Intent to Use) Biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; Contrasting agent for ultrasound diagnostic imaging; Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic reagents for medicinal use

(Based on Use in Commerce) Consulting services in the fields of diagnostic medical testing and nutrition; DNA screening for medical purposes; Drug, alcohol and DNA screening for medical purposes; Health assessment services, namely, providing a database in the field of sleep apnea and home sleep testing diagnostic information based on collected data and information all for treatment and diagnostic purposes; Health care services, namely, providing a database in the field of asthma and allergy information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes; Providing an internet web site for medical professionals and medical patients featuring information relating to sleep apnea and related diagnostic data input from remote locations via electronic patient monitoring devices that feed information to the web site for use by medical professionals for purposes of monitoring and diagnosing medical conditions; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Psychological services, namely, providing diagnostic services to children with special needs and their families; Web-based cardiovascular analysis services for medical diagnostic and treatment purposes; Web-based cardiovascular examination and assessment for medical diagnostic purposes

(Based on Intent to Use) Blood pressure and diabetic diagnostic medical devices; Diagnostic apparatus for the detection of cancer; Diagnostic apparatus for the detection of periodontal disease; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical diagnostic apparatus for detecting cancer; Medical diagnostic apparatus, analytical apparatus for medical purposes and blood pressure measuring apparatus; Medical diagnostic instruments for the analysis of body fluids; Medical instrument for cardiovascular diagnostics; Organoleptic diagnostic testing apparatus for medical, dental or cosmetic use; Orthopedic apparatus and instruments for diagnostic and therapeutic use; Orthopedic devices for diagnostic and therapeutic use; Radiological apparatus for diagnostic and medical purposes, namely, a helium-3 polarizer used for magnetic resonance imaging (MRI) of the lungs; Radiological apparatus for diagnostic and medical purposes, namely, magnetic resonance imager; Sample preparation device for medical diagnostic uses

(Based on Use in Commerce) Automotive diagnostic services featuring computer software for use by independent automotive repair personnel; Computer diagnostic services; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Diagnostic services in the field of medical and bio science; DNA analysis services; DNA analysis services to determine paternity; DNA screening for scientific research purposes; Drug, alcohol and DNA screening for forensic research purposes; Performing oil well diagnostics; Providing a website featuring information about investigational medical devices, diagnostic and drugs; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; Remote diagnosis of medical diagnostic imaging, clinical and biomedical equipment for determining the need for repair

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Nov 25, 2013 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Nov 25, 2013 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 23, 2013 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 26, 2013 NPUB
PUBLISHED FOR OPPOSITION
Feb 26, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 6, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 18, 2013 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 17, 2013 CNSA
DATA MODIFICATION COMPLETED
Jan 16, 2013 DMCC
DATA MODIFICATION COMPLETED
Jan 10, 2013 DMCC
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 17, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 17, 2012 CRFA
ASSIGNED TO LIE
Dec 10, 2012 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 7, 2012 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 7, 2012 GNRN
NON-FINAL ACTION E-MAILED
Jun 7, 2012 GNRT
NON-FINAL ACTION WRITTEN
Jun 7, 2012 CNRT
ASSIGNED TO EXAMINER
May 31, 2012 DOCK
NOTICE OF PSEUDO MARK MAILED
Feb 28, 2012 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 27, 2012 NWOS
NEW APPLICATION ENTERED
Feb 23, 2012 NWAP